🔗 Permalink

Inventor profile of:

Barbara Leuchs

City:

Heidelberg

Country:

Germany

Published Applications:

Last publication date:

2025-02-06

Top Assignees for applications by Barbara Leuchs

The entities that hold a legal rights for patent applications filed by inventor Leuchs Barbara:

Deutsches Krebsforschungszentrum 13 Heidelberg, Germany
RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG 3 Heidelberg, Germany
DEUTSCHES KREBSFORSCHUNGZENTRUM 2 HEIDELBERG, Germany
RUPRECHT-KARLS-UNIVERSITAET-HEIDELBERG 2 Heidelberg, Germany
RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG 2 Heidelberg, Germany
Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts 1 Heidelberg, Germany
Deutsches Krebsforschungszentrum Siftung des Öffentlichen Rechts 1 Heidelberg, Germany

Recent patent applications by Leuchs Barbara

Barbara Leuchs from Heidelberg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-06

US20250043251A1

Chemistry; metallurgy

METHOD FOR FURTHER UPSCALING THE LARGE-SCALE PRODUCTION OF THE ONCOLYTIC H-1 PROTOPARVOVIRUS (H-1PV) USING A CARRIER-BASED PRODUCTION PROCESS COMBINED WITH AN OPTIMIZED CELL CULTURE MEDIUM

#2 | 2024-06-06

US20240182907A1

Chemistry; metallurgy

H-1 PV EXPRESSING RNAi EFFECTORS

#3 | 2022-09-15

US20220290108A1

Chemistry; metallurgy

OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM

#4 | 2022-06-02

US20220169992A1

Chemistry; metallurgy

OPTIMIZED PARVOVIRUS H-1 PRODUCTION

#5 | 2021-07-29

US20210228714A1

Human necessities

Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor

#6 | 2020-12-10

US20200385738A1

Chemistry; metallurgy

H-1 PV EXPRESSING RNAI EFFECTORS TARGETING CDK9

#7 | 2020-07-09

US20200215134A1

Human necessities

Parvovirus formulation for treating tumors

#8 | 2019-08-22

US20190256823A1

Chemistry; metallurgy

Scalable process for oncolytic rat parvovirus H-1 production and purification based on isoelectric point-based elimination of empty particles

#9 | 2019-07-04

US20190203184A1

Chemistry; metallurgy

OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM

#10 | 2019-04-25

US20190117768A1

Human necessities

Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor

#11 | 2018-07-05

US20180187166A1

Chemistry; metallurgy

Method for large scale production and purification of parvovirus

#12 | 2018-04-26

US20180110813A1

Human necessities

Parvovirus formulation for treating tumors

#13 | 2017-09-21

US20170266244A1

Human necessities

Use of parvovirus for eliminating cancer stem cells (CSCs)

#14 | 2017-03-16

US20170073704A9

Chemistry; metallurgy

Adenovirus derived helper virus for enhancing recombinant parvovirus production

#15 | 2014-10-16

US20140310829A1

Chemistry; metallurgy

Modified parvovirus useful for gene silencing

#16 | 2014-07-24

US20140205573A1

Human necessities

Oncolytic virotherapy for the therapy of ewing'S sarcoma

#17 | 2013-08-29

US20130224154A1

Chemistry; metallurgy

Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of its capsid

#18 | 2013-08-15

US20130209413A1

Human necessities

Use of parvovirus for eliminating cancer stem cells (CSCs)

#19 | 2013-04-11

US20130089523A1

Chemistry; metallurgy

ADENOVIRUS DERIVED HELPER VIRUS FOR ENHANCING RECOMBINANT PARVOVIRUS PRODUCTION

#20 | 2013-01-31

US20130028913A1

Chemistry; metallurgy

Antibody that binds to H-1 parvovirus

InventorID:

65880 ⎘